Patients must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for EGFR and for oropharyngeal patients, HPV analyses
Patient must provide study-specific informed consent prior to study entry
Patient must be able to provide study-specific informed consent prior to study entry
Signed study-specific informed consent
Patient must be able to provide study specific informed consent prior to study entry
Patient must provide study specific informed consent prior to study entry
Signed study-specific informed consent prior to registration
Patient must be able to provide study-specific informed consent prior to study entry
The ability to provide written informed consent prior to study specific screening procedures, with the understanding that the patient has the right to withdraw from the study at any time
Patients must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for central review
Patient must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for epidermal growth factor receptor (EGFR) analysis and for oropharyngeal cancer patients, human papilloma virus (HPV) analysis
Patient must provide study specific informed consent prior to study entry, including consent for mandatory screening of tissue
Patient must provide study-specific informed consent prior to study entry
Patient must provide study specific informed consent prior to study entry, including the mandatory pre-treatment plasma EBV DNA assay
Provision of informed consent prior to any study specific procedures
Patient must provide study specific informed consent prior to study entry
Patient must provide study specific informed consent prior to study entry
Patients must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Patients must provide study-specific informed consent prior to registration
Patient must have provided study specific informed consent prior to study entry
Patient must provide study specific informed consent prior to study entry
Patients must sign a study-specific informed consent prior to study entry
The patient must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry, including consent for mandatory tumor tissue, serum, and blood submission for immune correlatives (all patients) and p16 analysis (oropharyngeal cases only)
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
The patient or a legally authorized representative must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
